Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
trending now
trending in pharma/biotech
trending in device
pharmagather
advertise
Legal Help
login/register
You are here
Home
»
companies
» diabetic neuropathy
diabetic neuropathy
BioDelivery Progresses with Clonidine Late-Stage Study
BioDelivery Progresses with Clonidine Late-Stage Study
Yahoo/Zacks
BioDelivery Sciences
diabetic neuropathy
clonidine topical gel
Flag link:
BioDelivery Sciences' Clonidine in Phase III Study
BioDelivery Sciences' Clonidine in Phase III Study
Yahoo/Zacks
pain management
diabetic neuropathy
clonidine topical gel
BioDelivery Sciences
Flag link:
BioDelivery Sciences Announces First Patient Enrollment in Phase 3 Clinical Study of Clonidine
BioDelivery Sciences Announces First Patient Enrollment in Phase 3 Clinical Study of Clonidine
Yahoo/Benzinga
clonidine
BioDelivery Sciences
diabetic neuropathy
Flag link:
Pfizer Reports Top-Line Results From Two Lyrica® Capsules CV Phase 3b Studies
Pfizer Reports Top-Line Results From Two Lyrica® Capsules CV Phase 3b Studies
Yahoo/BusinessWire
Lyrica
Pfizer
fibromyalgia
diabetic neuropathy
Flag link:
Pfizer Reports Results From Two Lyrica Capsules CV Phase 3b Studies
Pfizer Reports Results From Two Lyrica Capsules CV Phase 3b Studies
NASDAQ.com
Pfizer
Lyrica
fibromyalgia
diabetic neuropathy
Flag link:
AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
Yahoo
diabetic neuropathy
AbbVie
atrasentan
Flag link:
Sangamo Nerve Regrowth Drug Fails Key Test
Sangamo Nerve Regrowth Drug Fails Key Test
TheStreet.com
nerve regrowth
Sangamo BioSciences
SB-509
diabetic neuropathy
Flag link:
Sangamo's Phase II Results To Be Announced Monday - Expect Good News
Sangamo's Phase II Results To Be Announced Monday - Expect Good News
Seeking Alpha
Sangamo BioSciences
SB-509
diabetic neuropathy
Flag link:
Sangamo BioSciences to Host Conference Call to Discuss Results From Phase 2b Trial of SB-509 in Diabetic Neuropathy
Sangamo BioSciences to Host Conference Call to Discuss Results From Phase 2b Trial of SB-509 in Diabetic Neuropathy
Yahoo/PR NewsWire
Sangamo BioSciences
diabetic neuropathy
SB-509
Flag link:
The Wisdom Of The Crowds And Sangamo's Phase II B Clinical Trial Results
The Wisdom Of The Crowds And Sangamo's Phase II B Clinical Trial Results
Seeking Alpha
Sangamo BioSciences
SB-509
diabetic neuropathy
Flag link:
Sangamo BioSciences to raise $51M in stock offering Read more: Sangamo BioSciences to raise $51M in stock offering | San Francisco Business Times
Sangamo BioSciences to raise $51M in stock offering Read more: Sangamo BioSciences to raise $51M in stock offering | San Francisco Business Times
bizjournals.com
Sangamo BioSciences
diabetic neuropathy
DPP HIV
hemophilia
brain cancer
Flag link:
NeuroMetrix Hit by Lower Sales
NeuroMetrix Hit by Lower Sales
NeuroMetrix
investors
sales
diabetes
diabetic neuropathy
Flag link:
NeuroMetrix disbands direct sales, lays off 27 percent of workers
NeuroMetrix disbands direct sales, lays off 27 percent of workers
NeuroMetrix
diabetes
diabetic neuropathy
layoffs
Flag link: